DRMAW Financials
Dermata Therapeutics Inc. Warrant - Financial statements & key metrics
Stock Price
$0.00
Market Cap
-
P/E Ratio
-0.0
EPS
$-2.16
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-12.29M
EPS (Diluted)
$-8.03
Balance Sheet Highlights
Total Assets
$3.53M
Total Liabilities
$1.97M
Shareholders Equity
-
Cash & Equivalents
-
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-11.16M
CapEx
-
Free Cash Flow
-
Profitability Metrics
00
ROE
-203.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is DRMAW revenue?
View DRMAW's income statement for detailed revenue data.
Is DRMAW profitable?
DRMAW reported a loss of $12.29M in the most recent quarter.
What is DRMAW market cap?
Market cap data for DRMAW is available above.
Does DRMAW have debt?
View DRMAW's balance sheet for debt information.
What is DRMAW cash flow?
Cash flow data is available in the full financial statements.